Josh Riggs

Josh joined Oncocyte Corporation in August 2020 and was appointed Interim Chief Executive Officer in December 2022, after serving as Senior Director of Business Development and General Manager, Transplant. Josh is an experienced business leader and was previously the founder and principal of Intelligent Consulting, an organization devoted to consumer-driven healthcare, and a principal at Bethesda Group, LLC, a boutique consulting group focused on helping small and mid-stage diagnostic companies and investment groups move emerging diagnostic content and platforms to market.